Skip to main content
. 1998 Nov;42(11):3028–3031. doi: 10.1128/aac.42.11.3028

TABLE 2.

PAEs, SMEs, and PA-SMEs of quinupristin-dalfopristin for staphylococcia

Strain (drug susceptibility)b Mean (range) effect (h)
PAEc 0.1 × MIC
0.2 × MIC
0.3 × MIC
0.4 × MIC
SME PA-SME SME PA-SME SME PA-SME SME PA-SME
S. aureus (Metr Erys) 5.9 (5.4–6.1) 0 (0–0.2) 6.9 (6.6–7.1) 0.1 (0–0.3) 8.0 (7.8–8.2) 0.4 (0.3–0.6)  8.8 (8.6–9.0) 0.6 (0.5–0.7) 10.4 (10.1–10.6)
S. aureus (Metr Erys) 7.0 (6.7–7.3) 0 (0–0.1) 8.1 (7.9–8.3) 0.4 (0.1–0.8) 9.2 (8.9–9.5) 0.7 (0.4–0.9) 10.7 (10.4–11.1) 1.1 (0.8–1.2) 11.2 (10.1–12.7)
S. aureus (Metr Erys) 4.6 (4.1–5.1) 0 5.6 (5.0–6.0) 0 7.5 (6.7–8.7) 0.2 (0–0.4)  8.0 (7.6–8.5) 0.7 (0.5–1.5)  9.4 (9.2–9.5)
S. aureus (Metr inducibly Macr) 5.7 (5.2–6.3) 0 6.4 (5.5–6.8) 0.2 (0.1–0.3) 7.3 (6.6–7.9) 1.0 (0.8–1.3)  8.6 (7.7–9.3) 1.3 (1.2–1.6) 10.4 (8.8–11.6)
S. aureus (Metr inducibly Macr) 5.5 (5.1–5.8) 0.1 (0–0.2) 6.5 (6.0–7.1) 0.8 (0.3–0.9) 7.7 (7.2–8.4) 1.2 (1.1–1.4)  8.9 (8.5–9.8) 1.5 (1.2–1.8) 10.9 (9.8–12.9)
S. aureus (Metr constitutively Macr) 2.3 (1.9–2.7) 0.4 (0.3–0.6) 3.3 (3.1–3.5) 1.1 (0.9–1.4) 4.8 (4.2–5.2) 2.5 (1.6–3.2)  7.1 (6.6–7.5) 7.8 (6.3–9.0) 9.7 (8.5–10.7)
S. aureus (Metr constitutively Macr) 2.5 (2.2–2.9) 0 3.8 (3.2–4.3) 0.8 (0.2–1.4) 5.5 (3.9–7.3) 3.1 (2.4–3.5)  6.6 (5.4–8.8) 7.3 (6.4–8.2) 10.4 (9.3–12.5)
Coagulase-negative staphylococci (Mets) 4.7 (4.2–5.3) 0.3 (0.1–0.5) 4.9 (4.6–5.4) 0.4 (0.2–0.6) 5.3 (4.9–6.0) 0.4 (0.2–0.6)  5.6 (5.3–6.0) 0.8 (0.5–1.2)  6.6 (6.5–6.9)
Coagulase-negative staphylococci (Mets) 5.3 (4.6–5.8) 0.3 (0.1–0.4) 5.7 (4.8–6.3) 0.2 (0–0.4) 6.0 (4.6–6.9) 0.3 (0–0.6)  6.5 (5.4–7.1) 0.8 (0.3–1.2)  6.7 (6.0–7.1)
Coagulase-negative staphylococci (Metr) 4.0 (2.7–5.8) 0 4.0 (2.9–5.3) 0.1 (0–0.3) 4.6 (3.0–6.0) 0.3 (0–0.7)  4.6 (3.4–6.0) 0.3 (0–0.7)  5.9 (5.1–7.3)
Coagulase-negative staphylococci (Metr) 4.0 (3.6–4.4) 0 4.1 (3.5–4.5) 0.1 (0–0.4) 4.9 (4.1–5.6) 0.7 (0.4–1.3) 5.1 (4.4–5.6)  0.4 (0–0.6)  6.4 (5.9–7.3)
a

See Table 1, footnote a

b

Met, methicillin; Ery, erythromycin; Mac, macrolide; s, susceptible; r, resistant. 

c

Initial exposure concentration, 10 times the MIC.